Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01916538 · ClinicalTrials.gov registry record
Anorexia Nervosa Genetics Initiative
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 22,445
- Enrollment target
NCT01916538 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 22,445 participants.
The verdict
NCT01916538 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 22,445 participants
- Enrollment target
Study Summary
The Anorexia Nervosa Genetics Initiative (ANGI) is the largest and most rigorous genetic investigation of eating disorders ever conducted. Researchers in the United States, Sweden, Australia, and Denmark will collect clinical information and blood samples from over 13,000 individuals with anorexia nervosa and individuals without an eating disorder. ANGI represents a global effort to detect genetic variation that contributes to this potentially life-threatening illness. The goal of the research study is to transform knowledge about the causes of eating disorders to work toward greater understanding and ultimately a cure. If you have suffered from anorexia nervosa at any point in your life, you can help us achieve this goal. Your contribution would include a brief questionnaire and a blood sample. If you have never had anorexia nervosa, but still want to contribute, we invite your participation as well.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,445 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01916538
The ClinicalTrials.gov registry entry for NCT01916538 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22,445 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01916538 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01916538 about?
NCT01916538 is a clinical study titled "Anorexia Nervosa Genetics Initiative". The Anorexia Nervosa Genetics Initiative (ANGI) is the largest and most rigorous genetic investigation of eating disorders ever conducted. Researchers in the United States, Sweden, Australia, and Denmark will collect clinical information and blood samples from over 13,000 individuals with anorexia n...
What is the current status of trial NCT01916538?
This trial is currently completed. The enrollment target is 22,445 participants. The study started on 2013-06. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01916538?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.